Position in QURE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,723,519
+$619,453 QoQ
Shares Held
37,419
-44.6% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#111
of 254 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Jun 30, 2026CallValue
$829,080
CallShares
18,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Shay Capital LLC holds $28,920,887 across 40 Biotechnology names. QURE ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
80,000 | $3,763,200 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
44,000 | $3,586,440 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
12,500 | $2,341,000 | |
| 4 | MANE |
Veradermics, Inc
|
19,000 | $2,335,860 | |
| 5 | BCAX |
Bicara Therapeutics Inc.
|
68,000 | $2,018,920 | |
| 6 | QURE |
uniQure N.V.
This page
|
37,419 | $1,723,519 | |
| 7 | AVLN |
Avalyn Pharma Inc.
|
40,000 | $1,316,800 | |
| 8 | PGEN |
Precigen, Inc.
|
190,000 | $1,083,000 |
All Filings in QURE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,723,519 | 37,419 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $829,080 | 18,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $1,104,066 | 67,527 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $438,180 | 26,800 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $982,876 | 41,073 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,042,774 | 34,997 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,385,399 | 99,383 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $867,599 | 81,849 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,003,511 | 56,824 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $370,814 | 75,216 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $312,264 | 69,702 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $337,095 | 64,826 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $88,362 | 13,052 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||